| HIF transcription factors, inflammation, and immunity A Palazon, AW Goldrath, V Nizet, RS Johnson Immunity 41 (4), 518-528, 2014 | 1116 | 2014 |
| An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression A Palazon, PA Tyrakis, D Macias, P Veliça, H Rundqvist, S Fitzpatrick, ... Cancer cell 32 (5), 669-683. e5, 2017 | 420 | 2017 |
| S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate PA Tyrakis, A Palazon, D Macias, KL Lee, AT Phan, P Veliça, J You, ... Nature 540 (7632), 236-241, 2016 | 363 | 2016 |
| CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape A Rodriguez-Garcia, A Palazon, E Noguera-Ortega, DJ Powell Jr, ... Frontiers in immunology 11, 1109, 2020 | 219 | 2020 |
| Molecular pathways: hypoxia response in immune cells fighting or promoting cancer A Palazón, J Aragonés, A Morales-Kastresana, MO de Landázuri, ... Clinical Cancer Research 18 (5), 1207-1213, 2012 | 219 | 2012 |
| Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes C Alfaro, N Suarez, A Gonzalez, S Solano, L Erro, J Dubrot, A Palazon, ... British journal of cancer 100 (7), 1111-1119, 2009 | 219 | 2009 |
| Constitutive glycolytic metabolism supports CD8+ T cell effector memory differentiation during viral infection AT Phan, AL Doedens, A Palazon, PA Tyrakis, KP Cheung, RS Johnson, ... Immunity 45 (5), 1024-1037, 2016 | 202 | 2016 |
| The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy A Palazón, I Martínez-Forero, A Teijeira, A Morales-Kastresana, C Alfaro, ... Cancer discovery 2 (7), 608-623, 2012 | 190 | 2012 |
| Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes A Palazón, A Teijeira, I Martínez-Forero, S Hervás-Stubbs, C Roncal, ... Cancer research 71 (3), 801-811, 2011 | 179 | 2011 |
| Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ J Dubrot, F Milheiro, C Alfaro, A Palazón, I Martinez-Forero, ... Cancer Immunology, Immunotherapy 59, 1223-1233, 2010 | 179 | 2010 |
| SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum C Bruzzone, M Bizkarguenaga, R Gil-Redondo, T Diercks, E Arana, ... Iscience 23 (10), 2020 | 155 | 2020 |
| Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model A Morales-Kastresana, MF Sanmamed, I Rodriguez, A Palazon, ... Clinical Cancer Research 19 (22), 6151-6162, 2013 | 153 | 2013 |
| Immune response regulation in the tumor microenvironment by hypoxia S Labiano, A Palazon, I Melero Seminars in oncology 42 (3), 378-386, 2015 | 143 | 2015 |
| Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells SJ Dovedi, MJ Elder, C Yang, SI Sitnikova, L Irving, A Hansen, J Hair, ... Cancer Discovery 11 (5), 1100-1117, 2021 | 117 | 2021 |
| Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma O Murillo, A Arina, S Hervas-Stubbs, A Gupta, B McCluskey, J Dubrot, ... Clinical Cancer Research 14 (21), 6895-6906, 2008 | 98 | 2008 |
| Effects of IFN‐α as a signal‐3 cytokine on human naïve and antigen‐experienced CD8+ T cells S Hervas‐Stubbs, JI Riezu‐Boj, I Gonzalez, U Mancheño, J Dubrot, ... European journal of immunology 40 (12), 3389-3402, 2010 | 93 | 2010 |
| Structural characterization of N‐linked glycans in the receptor binding domain of the SARS‐CoV‐2 spike protein and their interactions with human lectins MP Lenza, I Oyenarte, T Diercks, JI Quintana, A Gimeno, H Coelho, ... Angewandte Chemie 132 (52), 23971-23979, 2020 | 90 | 2020 |
| Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN‐α A Rouzaut, S Garasa, Á Teijeira, I González, I Martinez‐Forero, N Suarez, ... European journal of immunology 40 (11), 3054-3063, 2010 | 88 | 2010 |
| In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb O Murillo, J Dubrot, A Palazon, A Arina, A Azpilikueta, C Alfaro, S Solano, ... European journal of immunology 39 (9), 2424-2436, 2009 | 84 | 2009 |
| The factor inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia J Sim, AS Cowburn, A Palazon, B Madhu, PA Tyrakis, D Macías, ... Cell metabolism 27 (4), 898-913. e7, 2018 | 77 | 2018 |
